During the last three months, 10 analysts shared their evaluations of Albemarle ALB, revealing diverse outlooks from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 0 | 1 | 7 | 2 | 0 |
Last 30D | 0 | 0 | 1 | 0 | 0 |
1M Ago | 0 | 1 | 3 | 2 | 0 |
2M Ago | 0 | 0 | 2 | 0 | 0 |
3M Ago | 0 | 0 | 1 | 0 | 0 |
In the assessment of 12-month price targets, analysts unveil insights for Albemarle, presenting an average target of $91.0, a high estimate of $122.00, and a low estimate of $68.00. Observing a downward trend, the current average is 3.53% lower than the prior average price target of $94.33.
Deciphering Analyst Ratings: An In-Depth Analysis
In examining recent analyst actions, we gain insights into how financial experts perceive Albemarle. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
---|---|---|---|---|---|
John Roberts | Mizuho | Lowers | Neutral | $85.00 | $90.00 |
Charles Neivert | Piper Sandler | Lowers | Underweight | $85.00 | $90.00 |
Vincent Andrews | Morgan Stanley | Lowers | Underweight | $68.00 | $73.00 |
Ben Isaacson | Scotiabank | Lowers | Sector Perform | $75.00 | $85.00 |
Aleksey Yefremov | Keybanc | Lowers | Overweight | $122.00 | $127.00 |
Peter Osterland | Truist Securities | Lowers | Hold | $85.00 | $96.00 |
Joshua Spector | UBS | Lowers | Neutral | $86.00 | $99.00 |
Peter Osterland | Truist Securities | Announces | Hold | $96.00 | - |
John Roberts | Mizuho | Lowers | Neutral | $105.00 | $110.00 |
Ben Kallo | Baird | Raises | Neutral | $103.00 | $79.00 |
Key Insights:
- Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Albemarle. This insight gives a snapshot of analysts' perspectives on the current state of the company.
- Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Albemarle compared to the broader market.
- Price Targets: Understanding forecasts, analysts offer estimates for Albemarle's future value. Examining the current and prior targets provides insight into analysts' changing expectations.
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Albemarle's market standing. Stay informed and make data-driven decisions with our Ratings Table.
Stay up to date on Albemarle analyst ratings.
Discovering Albemarle: A Closer Look
Albemarle is one of the world's largest lithium producers. In the lithium industry, the majority of demand comes from batteries, where lithium is used as the energy storage material, particularly in electric vehicles. Albemarle is a fully integrated lithium producer. Its upstream resources include salt brine deposits in Chile and the US and two hard rock mines in Australia, both of which are joint ventures. The company operates lithium refining plants in Chile, the US, Australia, and China. Albemarle is a global leader in the production of bromine, used in flame retardants. It is also a major producer of oil refining catalysts.
Unraveling the Financial Story of Albemarle
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
Negative Revenue Trend: Examining Albemarle's financials over 3 months reveals challenges. As of 31 December, 2024, the company experienced a decline of approximately -47.72% in revenue growth, reflecting a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Materials sector.
Net Margin: Albemarle's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of 2.73%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Albemarle's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 0.43%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): Albemarle's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of 0.2%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: Albemarle's debt-to-equity ratio is below the industry average at 0.47, reflecting a lower dependency on debt financing and a more conservative financial approach.
The Basics of Analyst Ratings
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. Click here to stay ahead of the market.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.